Insider · CIK 0001236389
Mark G Foletta
Files at DXCM (DEXCOM INC), AMN (AMN HEALTHCARE SERVICES INC), ENTA (ENANTA PHARMACEUTICALS INC). First filing Jun 18, 2025, latest Jun 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DXCM: DEXCOM INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | DEXCOM INC | $229k 2,750 shares | -5% | +39% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | DXCM DEXCOM INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -2,750 | $83.13 | $229k | 56,621 | Jun 18, 2025 |
| May 8, 2025 | DXCM DEXCOM INC | GGift Common Stock | -2,973 | $0.00 | $0 | 0 | May 12, 2025 |
| May 8, 2025 | DXCM DEXCOM INC | GGift Common Stockindirect: by Trust | +2,973 | $0.00 | $0 | 59,371 | May 12, 2025 |
| May 8, 2025 | DXCM DEXCOM INC | AGrant or award Common Stock | +5,731 | $0.00 | $0 | 5,731 | May 12, 2025 |
| May 2, 2025 | AMN AMN HEALTHCARE SERVICES INC | AGrant or award Restricted Stock Unitsderivative | +8,325 | $0.00 | $0 | 8,325 | May 6, 2025 |
| Apr 19, 2025 | AMN AMN HEALTHCARE SERVICES INC | MOption exercise Common Stock | +3,019 | $0.00 | $0 | 13,273 | Apr 21, 2025 |
| Apr 19, 2025 | AMN AMN HEALTHCARE SERVICES INC | MOption exercise Restricted Stock Unitsderivative | -3,019 | $0.00 | $0 | 0 | Apr 21, 2025 |
| Mar 13, 2025 | ENTA ENANTA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +15,700 | $0.00 | $0 | 15,700 | Mar 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.